Today I am spelling out the hot growth potential of three London-listed lovelies.
A bubbling beauty
Shares in drinks giant Britvic (LSE: BVIC) have endured a torrid time of late, the stock plunging to its cheapest since last September due to eroding risk appetite. But shares have bounced 4% in Wednesday business thanks to a broadly-positive trading update, and even though further turbulence may be on the cards I reckon the firm is a strong long-term share selection.
Britvic announced that revenues advanced 4.8% during the 20 weeks to December 20th, to 311.6m, although on an organic basis the figure declined 2.4% to 290.1m thanks to difficult trading conditions in Europe.
Still, the drinks play affirmed its earnings guidance of 180m-190m for 2016, and expects cost-saving measures and product investment to pay off handsomely. And I believe Britvics expansion in both developed and emerging markets the firm is due to roll out its Fruit Shoot range in the US in the coming months to deliver solid returns in the coming years.
In the meantime, the City expects Britvic to keep earnings rolling with a 6% advance in the year to September 2016, resulting in a very attractive P/E rating of 14.4 times. And a predicted dividend of 24.1p per share creates a handy yield of 3.4%.
A software star
Software builders Sage (LSE: SGE) also greeted the market with strong financial numbers in midweek trade, a development that drove also share values 4% higher from Tuesdays close.
The Newcastle-based business advised that organic revenues leapt 6.6% between October and December, with organic recurring revenues leaping 10.4% in the period. This result was driven by robust software subscription sales demand here galloped 35.7% in the quarter.
Although software and software-related services revenue drooped 5.3% in the period as Sage moves to a subscription-related model, the firm remains confident of recording a 6% organic revenues rise and a 27% operating margin for the full year to September 2016.
The calculator bashers expect Sage to record a 5% earnings advance in fiscal 2016, resulting in a slightly-high P/E rating of 23.3 times. But I reckon the companys market-leading software and solid pan-global presence fully merits this premium.
A tobacco titan
In periods of macroeconomic turbulence such as these, tobacco stocks like British American Tobacco (LSE: BATS) have often proved a wise investment destination thanks to the defensive nature of their operations.
Through exceptional brand strength British American Tobacco counts Lucky Strike and Pall Mall amongst its stable of products the company is able to keep revenues ticking higher even as wider economic troubles pressure consumer wallets.
And while global cigarette volumes are steadily sliding, British American Tobacco is chucking vast sums at the development and marketing of these labels to keep its own sales ticking higher. And as wealth levels in critical developing markets explode regions that are home to the vast majority of the worlds smokers I reckon the top line should keep on chugging higher at the cigarette giant.
The City expects British American Tobacco to record a 7% earnings advance in 2016, resulting in a reasonable P/E rating of 17 times. But it is in the dividend stakes where the London firm really blows away the competition a projected payout of 164.3p per share creates a delicious 4.3% yield.
So if you are looking for more growth greats like British American Tobacco et al, I strongly recommend you check out this special Fool report that identifies what I believe is one of the best growth stocks money can buy.
Our BRAND NEW “A Top Growth Share From The Motley Fool” report looks at a brilliant FTSE 250 stock that has already delivered stunning shareholder returns, and whose sales are expected to top the magic 1 billion marker in the coming years, according to the Fool’s crack team of analysts.
Click here to enjoy this exclusive ‘wealth report’ — it’s 100% free and comes with no obligation.